Medtronic said its indirect subsidiary Medtronic, Inc. issued €750,000,000 of 2.950% Senior Notes due 2030 and €750,000,000 of 4.200% Senior Notes due 2045 on September 29, 2025.

1. 01

   Medtronic said its indirect subsidiary Medtronic, Inc. issued €750,000,000 of 2.950% Senior Notes due 2030 and €750,000,000 of 4.200% Senior Notes due 2045 on September 29, 2025.

2. 02

   The company said Medtronic, Inc. expects to receive net proceeds of approximately €1.49 billion after deducting the underwriting discount and estimated offering expenses, and plans to use the proceeds to repay Medtronic Luxco's 0.000% and 2.625% Senior Notes due 2025.

3. 03

   Medtronic said on September 29, 2025 Medtronic Luxco redeemed all €500,000,000 of its outstanding 2.625% Senior Notes due 2025 at a redemption price equal to 100% of the principal amount, plus accrued and unpaid interest, and the redemption obligation was conditioned upon completion of the issuance and sale of the new Notes.

4. 04

   The company said the 2030 Notes mature on October 15, 2030 and the 2045 Notes mature on October 15, 2045, and prior to the Par Call Date, Medtronic, Inc. may redeem the Notes at a redemption price equal to the greater of 100% of the principal amount and a specified make-whole redemption price, plus accrued and unpaid interest.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.